London, UK: 1996), p. 1165.
3. Kornhuber, J., et al., Amantadine and memantine
are NMDA receptor antagonists with
neuroprotective properties. J. Neural Transm.
Suppl., 43, 91-104 (1994).
4. Nankai
NM_001194)). There were three further silent mutations (ATT-ATC (Ile - 919-
921 bp), CCT-CCC (Pro – 1165-1167 bp) and GCC-GCT (Ala – 1870-1872 bp))
and a single coding mutation AGG-GGG (Arg-Gly – 2545-2547